Considering nanogels, we have focused our attention on hybrid nanosystems for drug delivery and biomedical purposes. The distinctive strength of these structures is the capability to join the properties of nanosystems with the polymeric structures, where versatility is strongly demanded for biomedical applications. Alongside with the therapeutic effect, a non-secondary requirement of the nanosystem is indeed its biocompatibility. The importance to fulfill this aim is not only driven by the priority to reduce, as much as possible, the inflammatory or the immune response of the organism, but also by the need to improve circulation lifetime, biodistribution, and bioavailability of the carried drugs. In this framework, we have therefore gathered the hybrid nanogels specifically designed to increase their biocompatibility, evade the recognition by the immune system, and overcome the self-defense mechanisms present in the bloodstream of the host organism. The works have been essentially organized according to the hybrid morphologies and to the strategies adopted to fulfill these aims: Nanogels combined with nanoparticles or with liposomes, and involving polyethylene glycol chains or zwitterionic polymers.

Hybrid nanogels: Stealth and biocompatible structures for drug delivery applications / P. Eslami, F. Rossi, S. Fedeli. - In: PHARMACEUTICS. - ISSN 1999-4923. - 11:2(2019), pp. 71.1-71.24. [10.3390/pharmaceutics11020071]

Hybrid nanogels: Stealth and biocompatible structures for drug delivery applications

S. Fedeli
Ultimo
2019

Abstract

Considering nanogels, we have focused our attention on hybrid nanosystems for drug delivery and biomedical purposes. The distinctive strength of these structures is the capability to join the properties of nanosystems with the polymeric structures, where versatility is strongly demanded for biomedical applications. Alongside with the therapeutic effect, a non-secondary requirement of the nanosystem is indeed its biocompatibility. The importance to fulfill this aim is not only driven by the priority to reduce, as much as possible, the inflammatory or the immune response of the organism, but also by the need to improve circulation lifetime, biodistribution, and bioavailability of the carried drugs. In this framework, we have therefore gathered the hybrid nanogels specifically designed to increase their biocompatibility, evade the recognition by the immune system, and overcome the self-defense mechanisms present in the bloodstream of the host organism. The works have been essentially organized according to the hybrid morphologies and to the strategies adopted to fulfill these aims: Nanogels combined with nanoparticles or with liposomes, and involving polyethylene glycol chains or zwitterionic polymers.
Biocompatible carriers; Drug delivery; Nanogels; Nanohybrids; Nanolipogels; PEGylation; Stealth nanoparticles; Zwitterionic polymers
Settore CHEM-05/A - Chimica organica
2019
Article (author)
File in questo prodotto:
File Dimensione Formato  
pharmaceutics-11-00071-v2.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 12.91 MB
Formato Adobe PDF
12.91 MB Adobe PDF Visualizza/Apri
pharmaceutics-11-00071-v2_compressed.pdf

accesso aperto

Descrizione: File compresso
Tipologia: Publisher's version/PDF
Dimensione 1.37 MB
Formato Adobe PDF
1.37 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1102129
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 45
  • OpenAlex ND
social impact